Insulet | PODD - 流动负债



金融业
股票价格
USD
资产
USD 3.17B
现金及等价物
USD 534.9M
销售成本
USD 239.1M
流动资产
USD 1.85B
流动负债
USD 744.2M
债务
USD 948.4M
EBIT
USD 129.7M
EBITDA
USD 199.8M
员工
3.9K
EPS每股收益
USD 1.66
股本和储备
USD 1.42B
销售毛利
USD 562.6M
债务利息支出
USD 11M
利息收入
USD 4.9M
贷款资金
USD 929.5M
市值
USD 9.17B
净收入
USD 95M
营业费用
USD 672M
营业利润
USD 129.7M
普通股股本
USD 69.35M
PE价格收益
29.66
税前利润
USD 118.7M
销售收入
USD 801.7M
销售和管理费用
USD 344.8M
股票
USD 484.8M
贸易债权人
USD 123.3M
应收帐款人
USD 588.7M


流动负债 更改 日
Abbott USD 18.38B 1.88B 2026-03
Align Technology USD 1.91B 2.74M 2026-06
AtriCure USD 81.92M 8.72M 2026-06
Baxter International USD 3.59B 102M 2026-06
Becton, Dickinson and Co. USD 9.4B 897M 2026-06
Boston Scientific USD 6.43B 1.86B 2026-06
Cardinal Health USD 43.9B 1.92B 2026-06
Cooper Companies USD 1.87B 61.9M 2026-06
Dexcom USD 2.36B 133.9M 2026-06
Edwards Lifesciences USD 1.51B 98.9M 2026-06
Eli Lilly USD 47.74B 11.11B 2026-06
Globus Medical USD 479.35M 3.12M 2026-06
ICU Medical USD 498.36M 19.54M 2026-06
Inogen USD 64.94M 2.12M 2025-09
Insulet USD 744.2M 56.7M 2026-06
Integra LifeSciences USD 330.88M 15.96M 2026-06
J&J USD 54.9B 2.82B 2026-06
Medtronic USD 11.8B 141M 2026-06
Merit Medical Systems USD 264.93M 48.06M 2026-06
Roche Holding CHF 28.85B 846M 2026-06
Solventum Corp USD 3.66B 317M 2026-06
Stryker USD 6.68B 369M 2026-06
Tandem Diabetes Care USD 253M 5.05M 2026-06
Teleflex USD 720.38M 7.67M 2026-06
West Pharmaceutical Services USD 640.5M 33.5M 2026-06
Zimmer Biomet Holdings USD 3.01B 149.2M 2026-06